LATS1 and neoplasm: To validate our findings in vivo, we subcutaneously injected MEF Lats1/2 KO cells stably expressing TSSK1B WT and TSSK1B mutant (T174A) cells into BALB/c nude mice (N = 6) and monitored tumor development.